Gut reaction: Researchers define the colon's genomeJune 02, 2006For the first time, scientists describe the busy microbial world inside Rockville, MD— For the first time, scientists have defined the collective genome of the human gut, or colon. Up to 100 trillion microbes, representing more than 1,000 species, make up a motley "microbiome" that allows humans to digest much of what we eat, including some vitamins, sugars, and fiber. In a study published in the June 2 issue of Science, scientists at The Institute for Genomic Research (TIGR) and their colleagues describe and analyze the colon microbiome, which includes more than 60,000 genes—twice as many as found in the human genome. Some of these microbial genes code for enzymes that humans need to digest food, suggesting that bacteria in the colon co-evolved with their human host, to mutual benefit. "The GI tract has the most abundant, diverse population of bacteria in the human body," remarks lead author Steven Gill, a molecular biologist formerly at TIGR and now at the State University of New York in Buffalo. "We're entirely dependent on this microbial population for our well-being. A shift within this population, often leading to the absence or presence of beneficial microbes, can trigger defects in metabolism and development of diseases such as inflammatory bowel disease." As in studies of other animals, the scientists began by collecting droppings. They collected fecal samples from two anonymous, healthy adults who'd gone without antibiotics or other medications for a year prior to the study. The researchers created DNA libraries based on the samples, generating a total of 65,059 and 74,462 sequence reads, respectively, from the two subjects. They found evidence for several hundred bacterial phylotypes, most falling into two divisions of bacteria known as Firmicutes and Actinobacteria. In addition, a microbial organism known as a methanogenic archaeon, Methanobrevibacter smithii, was prominent. To assess the diversity of the colon microbiome, the researchers used two strategies. First, they matched their gut microbial DNA sequences up to two databases, one containing 16s rDNA gene sequences and the other containing non-redundant protein sequences. Second, they compared the colon-culled sequences to two previously sequenced human gut organisms: a bacterium, Bifidobacterium longum, and the archaeal microbe M. smithii. These known organisms showed striking similarity to much of the microbiome residents. Based on the sequence comparisons, the researchers conclude that the human GI tract hosts multiple strains of B. longum, and a majority of its archaeal species is related M. smithii. How many unique bacterial genera or species exist in the colon community? By comparison to the outside world, Gill suspects the human gut is at least as complex as our soils or seas. With the evidence at hand, the researchers have described greater diversity in the human gut than researchers have reported for samples of acid mine drainage. These microbes are busy, too. The new study shows that resident microbes in the colon actively synthesize vitamins and break down plant sugars, such as xylan and cellobiose (similar to cellulose), which humans could not otherwise digest because we lack the necessary enzymes. Cellobiose, for instance, is a key component of plant cell walls and thus is found in most edible plants, such as apples and carrots. The new study advances the growing field of metagenomics, or the study of many genomes found in a given ecosystem. Scientists at TIGR and elsewhere have recently scooped up whole environmental samples, from soil to sea, to study the diverse genomes contained within them. The idea is to survey a complex community in one fell swoop, examining how whole ecosystems of genomes respond to environmental perturbations—and, in the case of humans, how microbial ecosystems contribute to health and disease. "This study is an important first step toward identifying microbial differences between healthy people and those with conditions ranging from Crohn's Disease to cancer," says co-author Karen Nelson of TIGR, who has previously studied the guts of termites and other animals. "We might compare different individuals, with different diets, for instance." More broadly, the new work could become the opening salvo of a Human Microbiome Project that defines the microbial side of ourselves, suggests co-author Jeffrey Gordon, a microbiologist at Washington University in St. Louis. Gordon envisions such a project pursuing fundamental questions. How different are our microbiomes? Should differences in our microbiomes be viewed, along with our immune and nervous systems, as features of our biology that are affected by our individual environmental exposures? How is the human microbiome evolving as a function of our changing diets, lifestyle, and biosphere? Finally, how might we alter these microbial communities for better health in a person or population? The Institute for Genomic Research |
|||||||||||||||||||||
| Related Colon Current Events and Colon News Articles Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. Paradoxical protein might prevent cancer One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Minimally Invasive Surgery Shown Safe and Effective Treatment for Rectal Cancer Laparoscopic surgery has been used in the treatment of intestinal disorders for close to 20 years, but its benefits have only recently begun to be extended to people with rectal cancer. Curry-cure? Spicing up the effectiveness of a potential disease-fighter Scientists are reporting development of a nano-size capsule that boosts the body's uptake of curcumin, an ingredient in yellow curry now being evaluated in clinical trials for treatment of several diseases. Colon cancer screening more effective earlier in day, UCLA study finds The effectiveness of a screening colonoscopy may depend on the time of day it is performed. According to a new UCLA study, early-morning colonoscopies yielded more polyps per patient than later screenings, and fewer polyps were found hour by hour as the day progressed. Researchers use drug-radiation combo to eradicate lung cancer Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation. High-definition Colonoscopy Detects More Polyps, Mayo Clinic Researchers Say High-definition (HD) colonoscopy is much more sensitive than standard colonoscopy in finding polyps that could morph into cancer, say researchers at the Mayo Clinic campus in Florida. Toward bold new anti-cancer medicines Bold new strategies in the battle against cancer may turn forms of the disease that presently are incurable into manageable conditions that can be controlled for long periods of time. More Colon Current Events and Colon News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||